Anzemet
Company: Hoechst Marion Roussel
Approval Status: Approved February 1998
Treatment for: prevention of nausea and vomiting associated with chemotherapy and surgery
Areas: Oncology
Possible similar drugs: Anzemet
General Information
Other Useful Resources
Anzemet has been approved as an antiemetic that prevents nausea and vomiting associated with chemotherapy and surgery. Anzemet is available in both I.V. and oral formulations.
The FDA drug information shown here is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
